Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Amgen, a company that discovers, develops, manufactures and delivers human therapeutics, has appointed Jonathan Peacock as a new chief financial officer (CFO), effective September 1, 2010. Mr Peacock will report to Kevin Sharer, chairman and CEO of the company.
Subscribe to our email newsletter
Mr Peacock is expected to take up the responsibility for Amgen’s finance and investor relations operations. Most recently, Mr Peacock has served as the CFO and administration officer at Novartis Pharmaceutical since 2005.
In Novartis, Peacock was responsible for finance, information technology, purchasing, strategic planning and mergers and acquisitions functions.
Previously, Mr Peacock was a partner at McKinsey and Company, where he was co-leader of the European corporate finance practice working in the consulting firm’s Amsterdam, Zurich and London offices. He also was a partner at Price Waterhouse in New York and London.
Mr Sharer said: “I am delighted to have a leader of Jonathan’s talent, vision and international experience join Amgen at a time when we are expanding globally.”